Board hires

Market Access

The latest Board moves reflect a focus on experience in commercialisation, corporate governance, and therapeutic development.

News

Scribe Therapeutics has become the latest biotech to announce plans to list on the Nasdaq as it advances its spin on CRISPR-based therapeutics.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.